Mylan's shares dropped after it said that delays in launching key new drugs and lower prices for generics in the United States will hurt its profitability this and next year. Fred Katayama reports. Mylan's stock plunged after the maker of Epi …
HERTFORDSHIRE, England and PITTSBURGH, Nov. 10, 2017 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced that it is voluntarily delisting the company's ordinary shares from trading on the Tel Aviv Stock Exchange …
StockMarketWire.com - Indivior has confirmed that its US subsidiary, Indivior Inc, together with Monosol Rx, had entered into a settlement agreement with Mylan Pharmaceuticals, Mylan Technologies and Mylan NV resolving patent litigation …
Mylan could be facing another issue when it comes to the EpiPen, a drug used to treat severe allergic reactions that …
This week is almost all about the presidential election, which will resound throughout the stock market -- especially if Donald Trump is elected. Far more studies than not say the markets will tank if Trump surprises most pundits and …
One way to find these companies is by looking at several key metrics and financial ratios, many of which are crucial in the value stock selection process. Let’s put Mylan N.V. MYL stock into this equation and find out if it is a good choice for …